Clinical Trial: Ancillary Nocturnal Urinary Symptoms Analyses for TRIUMPH

U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07829029) titled 'Ancillary Nocturnal Urinary Symptoms Analyses for TRIUMPH' on Sept. 14.

Brief Summary: The TRIUMPH study is a randomized, double-blinded, 3-arm, parallel-group trial designed tocompare the effects of anticholinergic bladder therapy versus a) beta-3-adrenergic agonistbladder therapy and b) no bladder pharmacotherapy on cognitive, urinary, and other aging-related functional outcomes in ambulatory older women with urgency-predominant urinaryincontinence and either normal or mildly impaired cognitive function at baseline.

Study Start Date: Oct. 04, 2022

Study Type: INTERVENTIONAL

Condition: Nocturia Nocturnal Urinary Incontinence ...